• Publications
  • Influence
The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment
Objectives: To develop a 10‐minute cognitive screening tool (Montreal Cognitive Assessment, MoCA) to assist first‐line physicians in detection of mild cognitive impairment (MCI), a clinical stateExpand
  • 10,268
  • 1019
  • PDF
The Neuropsychiatric Inventory
We developed a new instrument, the Neuropsychiatric Inventory (NPI), to assess 10 behavioral disturbances occurring in dementia patients: delusions, hallucinations, dysphoria, anxiety,Expand
  • 4,688
  • 444
  • PDF
Frontotemporal lobar degeneration
Objective: To improve clinical recognition and provide research diagnostic criteria for three clinical syndromes associated with frontotemporal lobar degeneration. Methods: Consensus criteria for theExpand
  • 2,850
  • 190
  • PDF
Diagnosis and management of dementia with Lewy bodies
The dementia with Lewy bodies (DLB) Consortium has revised criteria for the clinical and pathologic diagnosis of DLB incorporating new information about the core clinical features and suggesting improved methods to assess them. Expand
  • 3,262
  • 146
  • PDF
Clinical diagnostic criteria for dementia associated with Parkinson's disease
Dementia has been increasingly more recognized to be a common feature in patients with Parkinson's disease (PD), especially in old age. Specific criteria for the clinical diagnosis of dementiaExpand
  • 1,946
  • 146
  • PDF
Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory.
The Neuropsychiatric Inventory (NPI) is a validated clinical instrument for evaluating psychopathology in dementia. The authors developed a brief questionnaire form of the NPI (NPI-Q), intended forExpand
  • 1,058
  • 118
The Neuropsychiatric Inventory
Article abstract-The Neuropsychiatric Inventory (NPI) was developed to assess psychopathology in dementia patients. It evaluates 12 neuropsychiatric disturbances common in dementia: delusions,Expand
  • 1,236
  • 106
  • PDF
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
In the past 8 years, both the International Working Group (IWG) and the US National Institute on Aging-Alzheimer's Association have contributed criteria for the diagnosis of Alzheimer's disease (AD)Expand
  • 1,904
  • 104
  • PDF
Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review)
Objective: The goal of this project was to determine whether screening different groups of elderly individuals in a general or specialty practice would be beneficial in detecting dementia.Expand
  • 2,000
  • 88
  • PDF
Revising the definition of Alzheimer's disease: a new lexicon
Alzheimer's disease (AD) is classically defined as a dual clinicopathological entity. The recent advances in use of reliable biomarkers of AD that provide in-vivo evidence of the disease hasExpand
  • 1,629
  • 69
  • PDF